Login to Your Account



Noven Adding Patch Technology to Japanese Firm in $428M Deal

By Jennifer Boggs


Wednesday, July 15, 2009
Japanese firm Hisamitsu Pharmaceutical Co. Inc. has offered to buy Noven Pharmaceuticals Inc. for about $428 million in a move that would combine transdermal drug delivery technologies of both firms and expand Hisamitsu's presence in the U.S. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription